Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO)
Dalmore Group's has more then $3.6B live reg A+ offerings
NEW YORK, July 22, 2024 /PRNewswire/ -- Onassis Holding Corp (OTC: ONSS), a wellness and biotech focused holding company, announced the launch of a Regulation A+ financing round. This follows an agreement with Dalmore Group.
Reg A+ provides a streamlined process for companies to raise up to $75 million annually from the public. In aligning with Dalmore Group, Onassis looks to leverage the investment bank's prowess in capital raising through Regulations A+, CF, and D. Since 2021, Dalmore has on-boarded over 270 Reg A+ issuers, establishing itself as a leader in Reg A+ financing services.
With over 16 years of experience and deep relationships in multiple financial markets, Dalmore provides strategic partnerships with experts in marketing and PR, syndication partnerships with several Reg A+ marketplace platform distribution partners, and secondary trading solutions for their Reg A+ issuers.
About Onassis Holdings Corp
Onassis Holdings Corp is a wellness and biotech holding company, specializing in healthcare, technology, and the epigenetic reprogramming for rejuvnation.
Forward-Looking Statements
Statements that are not historical or current facts are "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause the Company's actual results to differ materially from historical or future results. "Believes," "should," "intends," "will," or "plans" are considered uncertain and forward-looking statements.
Logo - https://mma.prnewswire.com/media/1708529/Onassis_Holdings_Corp_Logo.jpg
For more information about Onassis:
Onassis Holdings Corp.
+1-516-620-6794
[email protected]
www.ananda-labs.bio
SOURCE Onassis Holdings Corp
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article